Davidson Kempner Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,320,720
Closed -$942M 229
2020
Q1
$942M Buy
5,320,720
+62,135
+1% +$11.7M 25.15% 1
2019
Q4
$1.01B Buy
5,258,585
+453,870
+9% +$81.9M 22.65% 1
2019
Q3
$809M Buy
4,804,715
+3,739,715
+351% +$609M 15.89% 2
2019
Q2
$178M Buy
+1,065,000
New +$147M 1.93% 10
2016
Q2
Sell
-833,099
Closed -$223M 187
2016
Q1
$223M Buy
833,099
+495,388
+147% +$142M 4.74% 4
2015
Q4
$106M Buy
+337,711
New +$101M 1.89% 7
2015
Q2
Sell
-100,501
Closed -$29.9M 200
2015
Q1
$29.9M Buy
+100,501
New +$28.7M 0.63% 33
2014
Q4
Sell
-85,837
Closed -$20.7M 176
2014
Q3
$20.7M Buy
+85,837
New +$19.2M 0.47% 42
2013
Q4
Sell
-4,680
Closed -$674K 167
2013
Q3
$674K Sell
4,680
-1,720
-27% -$229K 0.02% 127
2013
Q2
$808K Buy
+6,400
New +$725K 0.04% 86

Other funds holding AGN

Davidson Kempner Capital Management's AGN Position: Q2 2020 in Review

Davidson Kempner Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,320,720 shares — an estimated $942M sold.

Davidson Kempner Capital Management first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $1.01B in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Davidson Kempner Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 5,320,720 Allergan plc shares in Q2 2020, an estimated $942M.
  • Davidson Kempner Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
  • Davidson Kempner Capital Management's Allergan plc position peaked at $1.01B in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.